Article Details

Daratumumab in Combination Therapies Safe, Effective for Relapsed/Refractory Multiple Myeloma

Retrieved on: 2021-07-08 15:33:45

Tags for this article:

Click the tags to see associated articles and topics

Daratumumab in Combination Therapies Safe, Effective for Relapsed/Refractory Multiple Myeloma. View article details on hiswai:

Excerpt

The monoclonal antibody daratumumab has been approved by the US ... that pertained to RRMM, monoclonal antibodies, daratumumab, and novel ...

Article found on: www.hematologyadvisor.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up